Rocket Pharmaceuticals, Inc.
RCKT
$2.93
-$0.14-4.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 12.27% | -6.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.70% | -9.69% | |||
| Operating Income | -2.70% | 9.69% | |||
| Income Before Tax | -1.67% | 9.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.67% | 9.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.67% | 9.58% | |||
| EBIT | -2.70% | 9.69% | |||
| EBITDA | -1.77% | 10.00% | |||
| EPS Basic | 9.93% | 12.72% | |||
| Normalized Basic EPS | 8.57% | 13.34% | |||
| EPS Diluted | 9.93% | 12.72% | |||
| Normalized Diluted EPS | 8.57% | 13.34% | |||
| Average Basic Shares Outstanding | 12.88% | 3.58% | |||
| Average Diluted Shares Outstanding | 12.88% | 3.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||